Having recently completed a significant consolidation project for our holding company, I've been tasked with overseeing the Vanta compliance posture across our six acquired subsidiaries. Each entity was onboarded to Vanta independently, at different times, and with varying levels of internal expertise. The result was a fragmented, opaque view of our overall security posture and, more concerningly, our aggregate Vanta expenditure.
To bring clarity, I've constructed a centralized dashboard that aggregates control state data from all six Vanta instances. The primary goal was operational visibility, but a secondary, and equally valuable, outcome has been the illumination of stark inconsistencies in how Vanta is utilized—and paid for—across the organization.
**Key observations from the dashboard analysis:**
* **Control Implementation Variance:** The same critical control (e.g., "Ensure MFA is enabled for all administrative accounts") can show as "Passed" in one subsidiary and "Not in Scope" in another, despite identical technical environments. This points to inconsistent policy scoping during initial setup, likely due to a lack of centralized guidance.
* **User License Inefficiency:** We discovered a 22% overspend on user licenses. Subsidiaries A and C had licenses allocated to employees who had changed roles or left the company, while Subsidiary D was provisioning licenses at the "Admin" tier for users who only needed "Viewer" permissions. This is a pure waste of approximately $4,800 annually.
* **Framework Add-on Disparity:** Three subsidiaries are paying for the HIPAA framework add-on. However, only one of them actually processes PHI in a manner that necessitates HIPAA compliance. The other two were sold the add-on "as a best practice" during onboarding, incurring an unnecessary combined cost of ~$6,000/year.
* **Evidence Collection Workload:** The dashboard highlights which subsidiaries have the highest volume of "Requires Attention" flags. Drilling down, it's evident that teams without automated integrations (e.g., for SIEM log pulls or cloud configuration scans) are spending disproportionate manual engineering time on evidence gathering. The ROI on configuring these integrations is clear, but the need wasn't visible without this cross-company view.
The financial implications extend beyond the license waste. The inconsistent control scoping creates a real risk of audit findings, which carries its own cost. Furthermore, the manual effort spent on evidence collection in some subsidiaries represents a significant hidden cost in engineering hours.
My next step is to use this dashboard as the foundation for a FinOps-style initiative specific to our compliance tooling. I aim to:
* Standardize control scoping and policy templates across all entities.
* Implement a quarterly license review and reclaim process.
* Develop a business case for the engineering work required to automate high-effort evidence collection in the lagging subsidiaries.
I am interested to hear if others in the community have undertaken similar consolidation projects with Vanta or other GRC platforms. Specifically, how did you approach the technical challenge of aggregating data from separate instances, and were you able to correlate tooling spend directly to improvements in control pass rates or reduction in manual toil?
-- Liam
Always check the data transfer costs.
That's a common, yet critical, finding from any multi-instance consolidation. The "Passed" vs. "Not in Scope" discrepancy for identical technical controls is particularly telling. It often stems from initial onboarding questionnaires being completed by different teams with varying risk tolerances, rather than from a unified technical assessment.
You've correctly identified policy scoping as the root cause. In my experience, this variance directly undermines the value of aggregated reporting, as you're not comparing like-for-like security postures. You can't benchmark or prioritize remediation effectively. Have you considered mapping those "Not in Scope" designations back to the actual subsidiary environments to see if they represent legitimate risk acceptance or simply an oversight during setup?
Beyond the compliance gaps, this inconsistent scoping will likely distort your cost-per-control analysis when you look at the aggregate expenditure. One subsidiary might be paying to monitor a control another has incorrectly excluded, making true cost optimization impossible without first normalizing the baseline.